Skip to content

Allergan

Also registered as Allergan, Inc.

Country not established

Allergan is a medical device manufacturer, with 1,745 devices listed in FDA GUDID, FDA 510(k) and FDA PMA (FDA Class III, Unclassified, Class II and Class I) and 5 FDA recalls as of 17 Nov 2026.

Devices
1,745
FDA recalls
5

Registry facts

Counted by deviCERTS from registry records, 17 Nov 2026

Registries
  • FDA GUDID 1,699
  • FDA 510(k) 39
  • FDA PMA 8

A device listed in two registries counts in both.

Device classes
  • FDA Class III 1,000
  • FDA Unclassified 714
  • FDA Class II 23
  • FDA Class I 8
Sites and related companies

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA recalls

What Allergan makes

The company manufactures silicone gel-filled and saline-filled breast implants with smooth surfaces, including cohesive and unstructured designs. It also produces invasive breast implant sizers in fixed, reusable and single-use versions, as well as skin-port tissue expanders and tissue expander injection ports. Additionally, it supplies dermal tissue reconstructive materials derived from microbes, with and without anaesthetic properties.

These devices are classified under FDA categories Class II, Class III, and Unclassified (U) and are listed in the FDA’s Unique Device Identifier (UDI) database.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1,745

Newest first, rows 1-50 of 1,745

Search and filter all 1,745 devices
Skip device list

Rows 1-50 of 1,745

Showing 1-50 of 1,745

FDA recalls5

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

  • 2015

    • 18 Jun 2015 Z-2103-2015 Class II Terminated Allergan is recalling the NATRELLE 133 and CUI Series Tissue Expanders because the product shipped was beyond the 47 month shelf life.via FDA establishment ALLERGAN Distribution: US in the state of Canada Submission number: K862203
    • 18 Jun 2015 Z-2104-2015 Class II Terminated Allergan is recalling the NATRELLE 133 and CUI Series Tissue Expanders because the products shipped were beyond the shelf life.via FDA establishment ALLERGAN Distribution: US in the state of Canada Submission number: K865056
    • 8 Jun 2015 Z-1988-2015 Class II Terminated Allergan is recalling the NATRELLE 410cc Re-Sterilizable Breast Implant Sizer because the expired product was shipped to the user level.via FDA establishment ALLERGAN Distribution: CA, IN, MO, NJ, VA Submission number: K831566
  • 2011

    • 21 Mar 2011 Z-2123-2011 Unclassified (pre-2012) Terminated The recall was initiated because Allergan has determined that a number of Access Port Needle pouches from one specific lot number may have small gaps in a pouch seal. Consequently the product may no longer be sterile.via FDA establishment ALLERGAN Distribution: Worldwide Distribution - USA including AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI,…
      Full distribution text Worldwide Distribution - USA including AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, MN, NV, NY, OH, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, and WV and the countries of Australia, Canada, Germany, Great Britian, and the Netherlands
      Submission number: P000008
  • 2010

    • 16 Sep 2010 Z-0418-2011 Unclassified (pre-2012) Terminated In a LAP-BAND System adjustment, failure to inject the needle perpendicular to the access port septum, as described in Directions for Use, may lead to port damage, resulting in subsequent port leakage. Leakage results in deflation of the LAP-BAND to its widest, open position requiring a procedure to replace the port. The patient may have symptoms of reduced satiety and increased appetite. Stallingvia FDA establishment ALLERGAN Distribution: Nationwide Distribution including AL, AR, AZ, CA, CO, CT, DC, FL, GA, ID, IL, IN, KY, LA, MA, ME, MI, MN, MO, MS, MT,…
      Full distribution text Nationwide Distribution including AL, AR, AZ, CA, CO, CT, DC, FL, GA, ID, IL, IN, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, WV, AND WY
      Submission number: P000008

Sites2

Frequently asked questions

How many devices does Allergan have in the registry?

The registry currently lists 1745 devices for Allergan. Devices recorded under merged duplicate company entries are counted once.

Which registries list Allergan's devices?

Among its 50 most recently registered devices, Allergan has devices listed in FDA 510(k) (1 device) and FDA GUDID (49 devices). A device can be listed in more than one registry, so these counts overlap.

What risk classes do Allergan's devices fall under?

Among its 50 most recently registered devices, the classes recorded for Allergan's devices are Class II and Class III. Each device page shows its own class and authorisation.

Are there FDA recall records for Allergan?

FDA recall records list 5 recalls initiated by Allergan, the most recent initiated on 18 Jun 2015. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Allergan in the registry?

The most recently registered devices listed for Allergan include XEN Glaucoma Treatment System 5513-001, XEN Glaucoma Treatment System, NATRELLE INSPIRA Single Use Sizers SSZ-M755 and NATRELLE INSPIRA Single Use Sizers SSZ-X400.

Generated automatically from registry data and not verified by a human reviewer.